Evidence map›Paper›PMID 38910416›Full record

ReviewCurrent pharmaceutical design2024

Current Insights in Murine Models for Breast Cancer: Present, Past and Future.

Mansi Jain, Anjana Goel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A One Health Perspective on Cancer: A Narrative Review.Medical sciences (Basel, Switzerland) · 2026
    Review
  2. FZD7 expression marks mammary tumor-initiating cells.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mansi JainDepartment of Biotechnology, GLA University, Mathura, India.ORCID 0009-0007-8200-6738
Anjana GoelDepartment of Biotechnology, GLA University, Mathura, India.ORCID 0000-0002-3759-184X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is an intricate disease that is increasing at a fast pace, and numerous heterogeneities within it further make it difficult to investigate. We have always used animal models to understand cancer pathology and create an

Indexed as

Breast NeoplasmsDisease Models, AnimalAnimalsFemaleHumansMicebreast cancer.chemically induced modelsgenetically engineered mouse models (GEMMs)metastasisMurine modelstransplantable models

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.